『An effective alternative to treating hyperlipidemia,

Release of Fenova tablets』

 

KyungDong Pharm Co., Ltd. will launch ‘Fenova Tablet’, a treatment for hyperlipidemia, on February 12th.

‘Fenova Tablet’ contains 160 mg of fenofibrate and is an effective drug for hypercholesterolemia and hypertriglyceridemia. ‘Fenova Tablet’ acts effectively on both cholesterol and triglycerides, and is especially effective in reducing triglycerides. Therefore, it shows an excellent lipid metabolism improvement effect when administered in combination with statin drugs in patients with combined dyslipidemia.

In addition, it has an excellent effect on raising HDL cholesterol compared to statin drugs, which are existing treatments for dyslipidemia, and reduces the risk of chronic heart disease by improving lipid metabolism.

‘Fenova Tablet’ is an efficient treatment for dyslipidemia patients and is expected to be of great help in managing triglyceride and HDL cholesterol levels along with KyungDong Pharm’s existing hyperlipidemia treatment.

 

 

        ☆ Product Information ☆

Product Name

Fenoba Tab

Ingredient content

Fenofibrate 160mg per tablet

Indications

Primary hyperlipidemia - hypercholesterolemia (type IIa)

Combined type of hypercholesterolemia and hypertriglyceridemia (type llb, type III),

Hypertriglyceridemia (type IV)

Dosage and usage

Adults: 160 mg of fenofibrate is administered orally once a day immediately after a meal.

Packaging unit

100 tablets

product code

648103470

 

※ Please refer to the product manual for further details such as dosage, usage precautions, etc.